For development-stage medical technology companies, regulatory approval and commercial revenue often sit years apart. A ...
GelrinC, Regentis Biomaterials’ cartilage-repair technology, received a Japanese Notice of Allowance for patent protection covering its organic solvent-free manufacturing process and ready-to-use ...
New Human Health Subsidiary to Advance Development of Innovative Biomaterial Technologies and Potential New Products for Human and Animal ...
Austin, Texas, August 14th, 2026, FinanceWireA new Japanese patent allowance follows a recent such US patent grant, ...
Marks Key IP Milestone For Gelrinc Manufacturing. Regentis Biomaterials (NYSE American: RGNT) is strengthening the manufacturing and intellectual property foundation behind its GelrinC cartilage-repai ...
Successful tissue regeneration can have major benefits in healing injuries or replacing portions of diseased or damaged tissue in bone, skin, the nervous system and in organs such as the muscle, ...
A group has proposed a new concept of mechanobiomaterials, which is inspired by the natural phenomenon that biomechanics mediate tissue repair and regeneration. The rationale behind this new concept ...
A study, published in Advanced Materials on May 6, 2024, led by VTT's researchers, introduces a transformative approach that integrates synthetic biology with advanced machine learning and ...
A new Japanese patent allowance follows a recent such US patent grant, strengthens protection around the organic solvent-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results